Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Net Cash Flow (2016 - 2025)

Iradimed (IRMD) has disclosed Net Cash Flow for 13 consecutive years, with -$5.4 million as the latest value for Q4 2025.

  • Quarterly Net Cash Flow fell 1147.99% to -$5.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.1 million through Dec 2025, down 143.5% year-over-year, with the annual reading at -$1.1 million for FY2025, 143.5% down from the prior year.
  • Net Cash Flow for Q4 2025 was -$5.4 million at Iradimed, down from $3.5 million in the prior quarter.
  • The five-year high for Net Cash Flow was $4.4 million in Q2 2021, with the low at -$15.2 million in Q1 2023.
  • Average Net Cash Flow over 5 years is $54473.5, with a median of $2.5 million recorded in 2022.
  • The sharpest move saw Net Cash Flow skyrocketed 430.62% in 2021, then crashed 1676.35% in 2022.
  • Over 5 years, Net Cash Flow stood at $3.6 million in 2021, then crashed by 34.71% to $2.4 million in 2022, then grew by 27.37% to $3.0 million in 2023, then crashed by 83.03% to $512147.0 in 2024, then plummeted by 1147.99% to -$5.4 million in 2025.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at -$5.4 million, $3.5 million, and $2.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.